Jeff Hall

Senior Editor, Diagnostic Imaging

Articles by Jeff Hall

Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?

In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.